These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9829852)

  • 21. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.
    Kristensen T; Vestergaard H; Bindslev-Jensen C; Møller MB; Broesby-Olsen S;
    Am J Hematol; 2014 May; 89(5):493-8. PubMed ID: 24443360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-kit mutation in a population of patients with mastocytosis.
    Nagata H; Okada T; Worobec AS; Semere T; Metcalfe DD
    Int Arch Allergy Immunol; 1997; 113(1-3):184-6. PubMed ID: 9130517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonality and molecular pathogenesis of mastocytosis.
    Akin C
    Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.
    Teodosio C; García-Montero AC; Jara-Acevedo M; Alvarez-Twose I; Sánchez-Muñoz L; Almeida J; Morgado JM; Matito A; Escribano L; Orfao A
    Leukemia; 2012 May; 26(5):951-8. PubMed ID: 22051531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review.
    Jenkinson HA; Lundgren AD; Carter MC; Diaz LZ; Levy ML
    Pediatr Dermatol; 2019 Jul; 36(4):486-489. PubMed ID: 30828864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilineage hematopoietic involvement in systemic mastocytosis.
    Akin C
    Leuk Res; 2003 Oct; 27(10):877-8. PubMed ID: 12860004
    [No Abstract]   [Full Text] [Related]  

  • 28. Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Mortz CG; Kjaer HF; Møller MB;
    Leuk Lymphoma; 2019 Jan; 60(1):268-270. PubMed ID: 29741430
    [No Abstract]   [Full Text] [Related]  

  • 29. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis.
    Dror Y; Leaker M; Caruana G; Bernstein A; Freedman MH
    Br J Haematol; 2000 Mar; 108(4):729-36. PubMed ID: 10792276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.
    Lanternier F; Cohen-Akenine A; Palmerini F; Feger F; Yang Y; Zermati Y; Barète S; Sans B; Baude C; Ghez D; Suarez F; Delarue R; Casassus P; Bodemer C; Catteau A; Soppelsa F; Hanssens K; Arock M; Sobol H; Fraitag S; Canioni D; Moussy A; Launay JM; Dubreuil P; Hermine O; Lortholary O;
    PLoS One; 2008 Apr; 3(4):e1906. PubMed ID: 18404201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.
    Papayannopoulou T; Kaushansky K
    Exp Hematol; 2016 Aug; 44(8):664-8. PubMed ID: 26773569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic and molecular genetic abnormalities in systemic mastocytosis.
    Gupta R; Bain BJ; Knight CL
    Acta Haematol; 2002; 107(2):123-8. PubMed ID: 11919394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
    Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
    J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
    Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
    Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
    Chan IJ; Tharp MD
    Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R634W KIT Mutation in an Adult With Systemic Mastocytosis.
    Astle JM; Rose MG; Racke FK; Tormey CA; Siddon AJ
    Lab Med; 2017 Aug; 48(3):253-257. PubMed ID: 28520972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new c-kit mutation in a case of aggressive mast cell disease.
    Pignon JM; Giraudier S; Duquesnoy P; Jouault H; Imbert M; Vainchenker W; Vernant JP; Tulliez M
    Br J Haematol; 1997 Feb; 96(2):374-6. PubMed ID: 9029028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.
    Féger F; Ribadeau Dumas A; Leriche L; Valent P; Arock M
    Int Arch Allergy Immunol; 2002 Feb; 127(2):110-4. PubMed ID: 11919418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.